TransCode Therapeutics, Inc. (Nasdaq: RNAZ), a clinical-stage oncology company developing RNA-targeted therapeutics for the treatment of cancer, today announced the appointment of Phillip D. Zamore, ...

Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, ...

PhaseV, a leader in AI/ML-driven clinical development, today announced a strategic partnership with the Crohn's & Colitis ...